ZA200808556B - Solid dispersions of poorly soluble drugs in graft copolymers - Google Patents
Solid dispersions of poorly soluble drugs in graft copolymersInfo
- Publication number
- ZA200808556B ZA200808556B ZA200808556A ZA200808556A ZA200808556B ZA 200808556 B ZA200808556 B ZA 200808556B ZA 200808556 A ZA200808556 A ZA 200808556A ZA 200808556 A ZA200808556 A ZA 200808556A ZA 200808556 B ZA200808556 B ZA 200808556B
- Authority
- ZA
- South Africa
- Prior art keywords
- poorly soluble
- graft copolymers
- solid dispersions
- soluble drugs
- drugs
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 229920000578 graft copolymer Polymers 0.000 title 1
- 239000007962 solid dispersion Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0607105.4A GB0607105D0 (en) | 2006-04-10 | 2006-04-10 | Enhancing solubility and dissolution rate of poorly soluble drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200808556B true ZA200808556B (en) | 2009-11-25 |
Family
ID=36539598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200808556A ZA200808556B (en) | 2006-04-10 | 2008-01-01 | Solid dispersions of poorly soluble drugs in graft copolymers |
Country Status (9)
Country | Link |
---|---|
US (1) | US20110059175A9 (zh) |
EP (1) | EP2004142A2 (zh) |
JP (1) | JP2009533357A (zh) |
CN (1) | CN101460148B (zh) |
CA (1) | CA2642757A1 (zh) |
GB (1) | GB0607105D0 (zh) |
IL (1) | IL194635A0 (zh) |
WO (1) | WO2007115381A2 (zh) |
ZA (1) | ZA200808556B (zh) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009042114A2 (en) | 2007-09-21 | 2009-04-02 | The Johns Hopkins University | Phenazine derivatives and uses thereof |
MX2010008945A (es) * | 2008-02-13 | 2010-09-07 | Bayer Schering Pharma Ag | Sistema de administracion de drogas con efecto estabilizante. |
ES2382618T3 (es) * | 2008-03-25 | 2012-06-11 | Formac Pharmaceuticals N.V. | Método de preparación para dispersiones sólidas |
US20120121703A1 (en) * | 2010-07-20 | 2012-05-17 | Japan Tobacco Inc. | Tablet containing ferric citrate |
US10463739B2 (en) | 2010-12-23 | 2019-11-05 | AbbVie Deutschland GmbH & Co. KG | Solid retard formulations based on solid dispersions |
CN102144982B (zh) * | 2011-03-30 | 2012-12-12 | 江苏神龙药业有限公司 | 一种米诺膦酸片及其制备方法 |
US20140178479A1 (en) * | 2011-08-12 | 2014-06-26 | Perosphere, Inc. | Concentrated Felbamate Formulations for Parenteral Administration |
US9044734B2 (en) | 2011-09-23 | 2015-06-02 | Basf Se | Diesel oxidation catalyst with layered structure containing ceria composition as palladium support material for enhanced HC and CO gas conversion |
EP2649989B1 (en) | 2012-04-13 | 2017-10-18 | King Saud University | Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof |
CN104379174B (zh) * | 2012-06-22 | 2018-01-26 | 巴斯夫欧洲公司 | 基于甲基丙烯酸二乙基氨基乙酯共聚物的含活性成分固体分散体 |
US10668156B2 (en) | 2012-06-22 | 2020-06-02 | Basf Se | Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers |
EP2919903B1 (en) | 2012-11-14 | 2020-07-22 | W.R. Grace & CO. - CONN. | Compositions containing a biologically active material and a non-ordered inorganic oxide |
US20160074396A1 (en) * | 2013-04-11 | 2016-03-17 | Ctc Bio, Inc. | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer |
US11116769B2 (en) | 2013-04-11 | 2021-09-14 | Ctc Bio, Inc. | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer |
CN103330685B (zh) * | 2013-07-08 | 2014-11-26 | 浙江昂利康制药有限公司 | 一种头孢克洛颗粒剂及其制备方法 |
CN103446075B (zh) * | 2013-09-04 | 2016-05-18 | 回音必集团浙江亚东制药有限公司 | 一种头孢克洛胶囊及其制备方法 |
US20150231081A1 (en) * | 2014-02-20 | 2015-08-20 | Cadila Healthcare Limited | Delayed release posaconazole tablets |
TWI525110B (zh) * | 2014-12-24 | 2016-03-11 | 財團法人工業技術研究院 | 聚合物、及包含其之醫藥組合物 |
US20180355165A1 (en) * | 2015-12-02 | 2018-12-13 | Nippon Shokubai Co., Ltd. | Water-soluble film and manufacturing method therefor |
WO2017115746A1 (ja) * | 2015-12-28 | 2017-07-06 | 沢井製薬株式会社 | ゲフィチニブ含有錠剤 |
CN105832680B (zh) * | 2016-05-12 | 2018-12-25 | 沈阳药科大学 | 一种改善螺内酯体外溶出及流动性的药物组合物 |
MX2019002880A (es) * | 2016-09-13 | 2019-07-04 | Procter & Gamble | Proceso para elaborar una composicion que comprende particulas de suministro de agente benefico. |
CN108261401B (zh) * | 2018-01-31 | 2021-01-08 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素固体分散体及伊维菌素片剂 |
CN117835971A (zh) * | 2021-08-25 | 2024-04-05 | 巴斯夫欧洲公司 | 直接压片用辅料组合物 |
CN114736263B (zh) * | 2022-03-08 | 2023-12-26 | 天津大学 | 一种二元共无定形物及其应用 |
WO2023187599A1 (en) * | 2022-03-27 | 2023-10-05 | Didenko Kirill | Methods and bioavailable highly permeable compounds for the treatment of viral diseases |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5633A (en) | 1848-06-13 | Improvement in water-wheels | ||
US15A (en) | 1836-08-31 | Cotton-planter | ||
DE1077430B (de) | 1958-04-15 | 1960-03-10 | Hoechst Ag | Verfahren zur Herstellung von Pfropfpolymerisaten von Polyvinylestern |
DE3536530A1 (de) | 1985-10-12 | 1987-04-23 | Basf Ag | Verwendung von pfropfcopolymerisaten aus polyalkylenoxiden und vinylacetat als vergrauungsinhibitoren beim waschen und nachbehandeln von synthesefasern enthaltendem textilgut |
US4957974A (en) * | 1988-03-29 | 1990-09-18 | Rohm And Haas Company | Graft copolymers and blends thereof with polyolefins |
DE4317172A1 (de) | 1993-05-22 | 1995-01-05 | Rhone Poulenc Rorer Gmbh | Geschmacksneutrale und schnellfreisetzende Buflomedil-Hydrochlorid-Arzneiform und Herstellungsverfahren desselben |
CA2240161C (en) * | 1996-05-20 | 2005-05-24 | Janssen Pharmaceutica N.V. | Antifungal compositions with improved bioavailability |
AU1511399A (en) * | 1997-12-31 | 1999-07-19 | Choongwae Pharma Corporation | Method and composition of an oral preparation of itraconazole |
US6630170B2 (en) * | 2001-04-26 | 2003-10-07 | Board Of Regents The University Of Texas System | Mesoporous compositions and method of preparation |
US20040208931A1 (en) * | 2002-12-30 | 2004-10-21 | Friend David R | Fast dissolving films for oral administration of drugs |
US20040242770A1 (en) * | 2003-04-16 | 2004-12-02 | Feldstein Mikhail M. | Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith |
US20050013863A1 (en) * | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
CA2531564C (en) * | 2003-07-18 | 2016-01-19 | Santarus, Inc. | Pharmaceutical composition for inhibiting acid secretion |
US7914971B2 (en) * | 2005-08-12 | 2011-03-29 | Semiconductor Energy Laboratory Co., Ltd. | Light exposure mask and method for manufacturing semiconductor device using the same |
PL1978936T3 (pl) * | 2006-02-03 | 2013-11-29 | Evonik Roehm Gmbh | Kompozycje farmaceutyczne zawierające mieszaniny polimerów i trudno rozpuszczalnych w wodzie substancji czynnych |
-
2006
- 2006-04-10 GB GBGB0607105.4A patent/GB0607105D0/en not_active Ceased
-
2007
- 2007-04-10 JP JP2009504531A patent/JP2009533357A/ja active Pending
- 2007-04-10 EP EP07719197A patent/EP2004142A2/en not_active Withdrawn
- 2007-04-10 WO PCT/BE2007/000033 patent/WO2007115381A2/en active Application Filing
- 2007-04-10 US US12/296,848 patent/US20110059175A9/en not_active Abandoned
- 2007-04-10 CN CN2007800207895A patent/CN101460148B/zh not_active Expired - Fee Related
- 2007-04-10 CA CA002642757A patent/CA2642757A1/en not_active Abandoned
-
2008
- 2008-01-01 ZA ZA200808556A patent/ZA200808556B/xx unknown
- 2008-10-07 IL IL194635A patent/IL194635A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2642757A1 (en) | 2007-10-18 |
CN101460148B (zh) | 2012-11-14 |
US20110059175A9 (en) | 2011-03-10 |
US20090311325A1 (en) | 2009-12-17 |
JP2009533357A (ja) | 2009-09-17 |
WO2007115381B1 (en) | 2008-02-14 |
CN101460148A (zh) | 2009-06-17 |
WO2007115381A2 (en) | 2007-10-18 |
GB0607105D0 (en) | 2006-05-17 |
EP2004142A2 (en) | 2008-12-24 |
WO2007115381A3 (en) | 2007-12-06 |
IL194635A0 (en) | 2009-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200808556B (en) | Solid dispersions of poorly soluble drugs in graft copolymers | |
EP1863859A4 (en) | GRAFT COPOLYMERS OF PEG-POLYACETAL AND PEG-POLYACETAL-POE AND PHARMACEUTICAL COMPOSITIONS | |
EP2010584A4 (en) | GRAFT POLYMERS AND USES THEREOF | |
EP2068776A4 (en) | VASCULAR STENT AND ITS PLACEMENT DEVICE | |
IL194751A0 (en) | Drugs and uses | |
EP1915449A4 (en) | SIRNA-HYDROPHILES POLYMERIC CONJUGATES FOR INTRA-CELLULAR INTRODUCTION OF SIRNA AND METHOD THEREFOR | |
EP1922019A4 (en) | TRI-BLOCK COPOLYMERS FOR MEDICINAL DISPENSING ON NANO BEADS BASE | |
PT1988910T (pt) | Acriloiloxietilfosforilcolina contendo conjugados de polímeros e sua preparação | |
EP1933881A4 (en) | SOLID POLYMER DISPENSING COMPOSITIONS AND APPLICATION METHOD THEREFOR | |
EP2162493A4 (en) | STABLE AND COMPATIBLE POLYMER MIXTURES | |
EP2119734A4 (en) | COPOLYMER AND ITS USE | |
PL2027208T3 (pl) | Amfifilowe kopolimery blokowe | |
EP2042138A4 (en) | PLASTER AND PAVER PREPARATION | |
GB2440619B (en) | Alkylacrylate copolymer dispersants and uses thereof | |
IL196861A0 (en) | Antibodies against ccr5 and uses thereof | |
EP2119442A4 (en) | PHARMACEUTICAL COMPOSITION WITH TACROLIMUS MAINTAINED RELEASE | |
EP2044980A4 (en) | SHEET TYPE OBJECT FOR A BALL, AND BALL | |
EP1976490A4 (en) | EXTENDED RELEASE TABLET CONTAINING ZALTOPROFEN AND PROCESS FOR PREPARING SAID TABLET | |
EP2053069A4 (en) | HYDROPHILIC POLYMER | |
IL193541A0 (en) | Polymer dispersions comprising effect substances and use thereof | |
EP2127677A4 (en) | AMINO ALKYL METHACRYLATE COPOLYMER FOR MAINTAINING THE SOLUBILITY OF A HEAVY WATER-SOLUBLE MEDICAMENT | |
IL199991A0 (en) | Soluble fcgammaria and related methods | |
GB0610090D0 (en) | Particulate drug compositions and their uses | |
EP1988082A4 (en) | MULTICOLORED COMPLEX AND POLYMER THEREOF | |
GB0611422D0 (en) | Polymeric particles and their preparation |